close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

185.06 +1.02 (+0.55%)
Streaming Delayed Price Updated: 2:16 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 6.1% in the afternoon session after the company provided an encouraging business update at an investor conference,... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
These S&P500 stocks are moving in today's pre-market session ↗
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
These S&P500 stocks are moving in today's session ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
News headline image
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest
Looking back on drug development inputs & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers. 
Via StockStory
News headline image
5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call
Charles River Laboratories’ third quarter results were met with negative market reaction, as investors focused on the company’s muted top-line growth and margin pressures. Management cited ongoing... 
Via StockStory
Topics Earnings
News headline image
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
News headline image
Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility
Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
This Charles River Laboratories Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook
Lab services company Charles River Laboratories (NYSE:CRL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.00 billion. Its non-GAAP profit... 
Via StockStory
News headline image
Charles River (CRL) Q3 2025 Earnings Transcript ↗
Charles River (CRL) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Charles River Beat Expectations But Why Is The Stock Falling? ↗
Charles River stock dips as Q3 revenue slips, EPS beats estimates, and company raises 2025 outlook with cost cuts and $1 billion buyback plan. 
Via Benzinga
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today
Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after the company reported third-quarter results that revealed significant underlying weaknesses. 
Via StockStory
Topics Artificial Intelligence
News headline image
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Charles River Laboratories (NYSE:CRL) Tops Q3 Earnings Estimates Despite Flat Revenue ↗
Charles River Labs Q3 earnings beat estimates with $2.43 EPS. The company raised its full-year EPS guidance while navigating a slight revenue decline. 
Via Chartmill
Topics Earnings
News headline image
Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue
Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share... 
Via StockStory
News headline image
What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings
Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Discover which S&P500 stocks are making waves on Thursday. ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday. 
Via Chartmill
News headline image
3 Reasons to Avoid CRL and 1 Stock to Buy Instead
The past six months have been a windfall for Charles River Laboratories’s shareholders. The company’s stock price has jumped 60.1%, hitting $170.64 per share. This was partly due to its solid quarterly... 
Via StockStory
News headline image
Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Charles River Laboratories (NYSE:CRL) and its peers. 
Via StockStory
News headline image
Why Charles River Stock May Struggle In Its Final Phase ↗
Adhishthana.com notes Charles River Stock is nearing its Phase 18, with momentum weakening and long-term outperformance looking unlikely. 
Via Benzinga
News headline image
Charles River Laboratories (CRL) Stock Is Up, What You Need To Know
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 2.6% in the afternoon session after the stock's positive momentum continued, as Barclays upgraded the company to Overweight... 
Via StockStory
News headline image
What's going on in today's session: S&P500 movers ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
News headline image
Why Charles River Laboratories (CRL) Stock Is Up Today
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target. 
Via StockStory
Topics Government
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today